Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing
Vivos Inc. received its Washington State Radioactive Materials License, clearing the path for in-house manufacturing of its IsoPet cancer therapy for animals. The license allows production at the company’s new domestic facility in Richland, Washington, enabling the first production run and shipment in the near future.
Key figures
- Radiogel status
- Amendment application pending
- Isopet manufacturing status
- License received, production imminent
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.